Practical metabolomics in drug discovery

Expert Opinion on Drug Discovery

Volumn 5, Issue 3, 2010, Pages 249-263

  Wilcoxen, Keith M ^a   Uehara, Taisuke ^b   Myint, Khin Than ^c   Sato, Yoshiaki ^b   Oda, Yoshiya ^a  

^a EISAI INC   (United States)

^b EISAI CO LTD   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Biomarker; Drug discovery; Liquid chromatography; Mass spectroscopy; Metabolome; Metabolomics

Indexed keywords

AMINO ACID; BIOLOGICAL MARKER; DRUG; LIPID; SUGAR;

BIOINFORMATICS; BODY FLUID; DRUG EFFICACY; DRUG INDUSTRY; DRUG SAFETY; HUMAN; METABOLOMICS; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 77749331015     PISSN: 17460441     EISSN: None     Source Type: Journal    
DOI: 10.1517/17460441003631854     Document Type: Review

References (99)

1. Schadt Eric E, Friend Stephen H, Shaywitz David A. A network view of disease and compound screening. Nat Rev Drug Discov 2009;8(4):286-295
2. Ganter B, Giroux Craig N. Emerging applications of network and pathway analysis in drug discovery and development. Curr Opin Drug Discov Devel 2008;11(1):86-94
3. Weckwerth W. Metabolomics in systems biology. Ann Rev Plant Biol 2003;54:669-689
4. Wishart DS, Knox C, Guo AC, et al. HMDB: a knowledge-base for the human metabolome. Nucleic Acids Res 2009;37(Database):D603-10
5. Dettmer K, Aronov Pavel A, Hammock Bruce D. Mass spectrometry-based metabolomics. Mass Spectrom Rev 2007;26(1):51-78
6. Lenz EM, Bright J, Knight R, et al. Cyclosporin A-induced changes in endogenous metabolites in rat urine: a metabonomic investigation using high field 1H NMRspectroscopy, HPLC-TOF/ MS and chemometrics. J Pharm Biomed Anal 2004;35(3):599-608
7. Williams RE, Major H, Lock EA, et al. D-Serine-induced nephrotoxicity: a HPLC-TOF/MS-based metabonomics approach. Toxicology 2005;207(2):179-190
8. Issaq Haleem J, Abbott E, Veenstra Timothy D. Utility of separation science in metabolomic studies. J Sep Sci 2008;31(11):1936-1947
9. Want EJ, O'Maille G, Smith CA, et al. Solvent-dependent metabolite distribution, clustering, and protein extraction for serum profiling with mass spectrometry. Anal Chem 2006;78(3):743-752
10. Le Belle JE, Harris NG, Williams SR, Bhakoo KK. A comparison of cell and tissue extraction techniques using high-resolution 1H-NMR spectroscopy. NMR Biomed 2002;15(1):37-44
11. Canelas AB, ten Pierick A, Ras C, et al. Quantitative evaluation of intracellular metabolite extraction techniques for yeast metabolomics. Anal Chem 2009;81(17):7379-7389
12. Tiziani S, Emwas A-H, Lodi A, et al. Optimized metabolite extraction from blood serum for 1H nuclear magnetic resonance spectroscopy. Anal Biochem 2008;377(1):16-23
13. Michopoulos F, Lai L, Gika H, et al. UPLC-MS-based analysis of human metabonomics plasma for solvent precipitation using solvent precipitation or solid phase extraction. J Proteome Res 2009;8(4):2114-2121
14. Wenk MR. The emerging field of lipidomics. Nat Rev Drug Discov 2005;4(7):594-610
15. Watson AD. Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res 2006;47(10):2101-2111
16. Steinberg D. Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy: part II: the early evidence linking hypercholesterolemia to coronary disease in humans. J Lipid Res 2005;46(2):179-190
17. Hu C, van der Heijden R, Wang M, et al. Analytical strategies in lipidomics and applications in disease biomarker discovery. J Chromatogr B Analyt Technol Biomed Life Sci 2009;877(26):2836-2846
18. Fernandis AZ, Wenk MR. Lipid-based biomarkers for cancer. J Chromatogr B Analyt Technol Biomed Life Sci 2009;877(26):2830-2835
19. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37(8):911-917
20. Alvarez JG, Touchstone JC. Separation of acidic and neutral lipids by aminopropyl-bonded silica gel column chromatography. J Chromatogr B Biomed Sci Appl 1992;577(1):142-145
21. Ogiso H, Suzuki T, Taguchi R. Development of a reverse-phase liquid chromatography electrospray ionization mass spectrometry method for lipidomics, improving detection of phosphatidic acid and phosphatidylserine. Anal Biochem 2008;375(1):124-131
22. Johanson RA, Berry GT. Brain phosphoinositide extraction, fractionation, and analysis by MALDI-TOF MS. Methods Mol Biol 2009;579:189-200
23. Christie WW. Literature Survey-Solid Phase Extraction and Lipids. 2009; Available from: http://lipidlibrary.aocs. org/lit-surv/general/lit-spe.htm [Last accessed 12 September 2009]
24. Brown MJ, Pleasure DE, Asbury AK. Microdissection of peripheral nerve: collagen and lipid distribution with morphological correlation. J Neurol Sci 1976;29(2-4):361-369
25. Shimma S, Sugiura Y, Hayasaka T, et al. MALDI-based imaging mass spectrometry revealed abnormal distribution of phospholipids in colon cancer liver metastasis. J Chromatogr B Analyt Technol Biomed Life Sci 2007;855(1):98-103
26. Roy S, Touboul D, Brunelle A, et al. Imaging mass spectrometry: a new tool for the analysis of skin biopsy. Application in Fabry's disease. Ann Pharm Fr 2006;64(5):328-334
27. Griffiths William J, Wang Y. Mass spectrometry: from proteomics to metabolomics and lipidomics. Chem Soc Rev 2009;38(7):1882-1896
28. Griffiths WJ, Wang Y. Mass spectrometry: from proteomics to metabolomics and lipidomics. Chem Soc Rev 2009;38(7):1882-1896
29. Kanani H, Chrysanthopoulos Panagiotis K, Klapa Maria I. Standardizing GC-MS metabolomics. J Chromatogr B Analyt Technol Biomed Life Sci 2008;871(2):191-201
30. Soga T, Ohashi Y, Ueno Y, et al. Quantitative metabolome analysis using capillary electrophoresis mass spectrometry. J Proteome Res 2003;2(5):488-494
31. Wishart DS, Lewis MJ, Morrissey JA, et al. The human cerebrospinal fluid metabolome. J Chromatogr B Analyt Technol Biomed Life Sci 2008;871(2):164-173
32. Yu K, Sheng G, Sheng J, et al. A metabonomic investigation on the biochemical perturbation in liver failure patients caused by hepatitis B virus. J Proteome Res 2007;6(7):2413-2419
33. Myint Khin T, Aoshima K, Tanaka S, et al. Quantitative profiling of polar cationic metabolites in human cerebrospinal fluid by reversed-phase nanoliquid chromatography/mass spectrometry. Anal Chem 2009;81(3):1121-1129
34. Myint Khin T, Uehara T, Aoshima K, Oda Y. Polar anionic metabolome analysis by nano-LC/MS with a metal chelating agent. Anal Chem 2009;81(18):7766-7772
35. Nordstrom A, O'Maille G, Qin C, Siuzdak G. Nonlinear data alignment for UPLC-MS and HPLC-MS based metabolomics: quantitative analysis of endogenous and exogenous metabolites in human serum. Anal Chem 2006;78(10):3289-3295
36. Wilson ID, Nicholson JK, Castro-Perez J, et al. High resolution "Ultra Performance" liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies. J Proteome Res 2005;4(2):591-598
37. Evans AM, De Haven CD, Barrett T, et al. Integrated, nontargeted ultrahigh performance liquid chromatography/ electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal Chem 2009;81(16):6656- 6667
38. Schmidt A, Karas M, Dulcks T. Effect of different solution flow rates on analyte ion signals in nano-ESI MS, or: when does ESI turn into nano-ESI? J Am Soc Mass Spectrom 2003;14(5):492-500
39. Tang K, Page JS, Smith RD. Charge competition and the linear dynamic range of detection in electrospray ionization mass spectrometry. J Am Soc Mass Spectrom 2004;15(10):1416-1423
40. Metz TO, Page JS, Baker ES, et al. High-resolution separations and improved ion production and transmission in metabolomics. Trends Anal Chem 2008;27(3):205-214
41. Granger J, Plumb R, Castro-Perez J, Wilson ID. Metabonomic studies comparing capillary and conventional HPLC-oa-TOF MS for the analysis of urine from Zucker obese rats. Chromatographia 2005;61(7/8):375-380
42. Buscher JM, Czernik D, Ewald JC, et al. Cross-platform comparison of methods for quantitative metabolomics of primary metabolism. Anal Chem 2009;81(6):2135-2143
43. Alpert AJ. Hydrophilic-interaction chromatography for the separation of peptides, nucleic acids and other polar compounds. J Chromatogr 1990;499:177-196
44. Tolstikov Vladimir V, Fiehn O. Analysis of highly polar compounds of plant origin: combination of hydrophilic interaction chromatography and electrospray ion trap mass spectrometry. Anal Biochem 2002;301(2):298-307
45. Bruce SJ, Tavazzi I, Parisod V, et al. Investigation of human blood plasma sample preparation for performing metabolomics using ultrahigh performance liquid chromatography/mass spectrometry. Anal Chem 2009;81(9):3285-3296
46. Uehara T, Yokoi A, Aoshima K, et al. Quantitative phosphorus metabolomics using nanoflow liquid chromatography-tandem mass spectrometry and culture-derived comprehensive global internal standards. Anal Chem 2009;81(10):3836-3842
47. Wu L, Mashego Mlawule R, van Dam Jan C, et al. Quantitative analysis of the microbial metabolome by isotope dilution mass spectrometry using uniformly 13C-labeled cell extracts as internal standards. Anal Biochem 2005;336(2):164-171
48. Sas B, Peys E, Helsen M. Efficient method for (lyso)phospholipid class separation by high-performance liquid chromatography using an evaporative light-scattering detector. J Chromatogr A 1999;864(1):179-182
49. Jaaskelainen I, Urtti A. Liquid chromatography determination of liposome components using a light-scattering evaporative detector. J Pharm Biomed Anal 1994;12(8):977-982
50. Taguchi R, Houjou T, Nakanishi H, et al. Focused lipidomics by tandem mass spectrometry. J Chromatography B Analyt Technol Biomed Life Sci 2005;823(1):26-36
51. Han X, Gross RW. Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomics. J Lipid Res 2003;44(6):1071-1079
52. Han X, Gross RW. Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples. Mass Spectrom Rev 2005;24(3):367-412
53. Han X, Gross RW. Shotgun lipidomics: multidimensional MS analysis of cellular lipidomes. Expert Rev Proteomics 2005;2(2):253-264
54. Han X, Yang J, Cheng H, et al. Toward fingerprinting cellular lipidomes directly from biological samples by two-dimensional electrospray ionization mass spectrometry. Anal Biochem 2004;330(2):317-331
55. Taguchi R. Systems for lipidomics: metabolomics focused on lipids. Tanpakushitsu Kakusan Koso 2004;49(Suppl 11):1911-1916
56. Houjou T, Yamatani K, Nakanishi H, et al. Rapid and selective identification of molecular species in phosphatidylcholine and sphingomyelin by conditional neutral loss scanning and MS3. Rapid Commun Mass Spectrom 2004;18(24):3123-3130
57. Houjou T, Yamatani K, Imagawa M, et al. A shotgun tandem mass spectrometric analysis of phospholipids with normal-phase and/or reverse-phase liquid chromatography/electrospray ionization mass spectrometry. Rapid Commun Mass Spectrom 2005;19(5):654-666
58. Milne S, Ivanova P, Forrester J, Alex Brown H. Lipidomics: an analysis of cellular lipids by ESI-MS. Methods 2006;39(2):92-103
59. Han X, Yang K, Yang J, et al. Shotgun lipidomics of cardiolipin molecular species in lipid extracts of biological samples. J Lipid Res 2006;47(4):864-879
60. Han X, D MH, McKeel DW Jr, et al. Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis. J Neurochem 2002;82(4):809-818
61. Fuller M, Sharp PC, Rozaklis T, et al. Urinary lipid profiling for the identification of fabry hemizygotes and heterozygotes. Clin Chem 2005;51(4):688-694
62. Zamfir A, Vakhrushev S, Sterling A, et al. Fully automated chip-based mass spectrometry for complex carbohydrate system analysis. Anal Chem 2004;76(7):2046-2054
63. Taguchi R, Nishijima M, Shimizu T. Basic analytical systems for lipidomics by mass spectrometry in Japan. Methods Enzymol 2007;432:185-211
64. Ikeda K, Oike Y, Shimizu T, Taguchi R. Global analysis of triacylglycerols including oxidized molecular species by reverse-phase high resolution LC/ESI-QTOF MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2009;877(25):2639-2647
65. Rainville PD, Stumpf CL, Shockcor JP, et al. Novel application of reversed-phase UPLC-oaTOF-MS for lipid analysis in complex biological mixtures: a new tool for lipidomics. J Proteome Res 2007;6(2):552-558
66. Yetukuri L, Katajamaa M, Medina-Gomez G, et al. Bioinformatics strategies for lipidomics analysis: characterization of obesity related hepatic steatosis. BMC Syst Biol 2007;1:12
67. Kolak M, Westerbacka J, Velagapudi VR, et al. Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity. Diabetes 2007;56(8):1960-1968
68. Kirsch S, Muthing J, Peter-Katalinic J, Bindila L. On-line nano-HPLC/ESI QTOF MS monitoring of alpha2-3 and alpha2-6 sialylation in granulocyte glycosphingolipidome. Biol Chem 2009;390(7):657-672
69. Kim H, Ahn E, Moon MH. Profiling of human urinary phospholipids by nanoflow liquid chromatography/tandem mass spectrometry. Analyst 2008;133(12):1656-1663
70. Ahn EJ, Kim H, Chung BC, et al. Quantitative profiling of phosphatidylcholine and phosphatidylethanolamine in a steatosis/ fibrosis model of rat liver by nanoflow liquid chromatography/tandem mass spectrometry. J Chromatogr A 2008;1194(1):96-102
71. Bang DY, Ahn E, Moon MH. Shotgun analysis of phospholipids from mouse liver and brain by nanoflow liquid chromatography/tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2007;852(1-2):268-277 (Pubitemid 46830119)
72. He H, Conrad CA, Nilsson CL, et al. Method for lipidomic analysis: p53 expression modulation of sulfatide, ganglioside, and phospholipid composition of U87 MG glioblastoma cells. Anal Chem 2007;79(22):8423-8430
73. Bang DY, Kang D, Moon MH. Nanoflow liquid chromatography-tandem mass spectrometry for the characterization of intact phosphatidylcholines from soybean, bovine brain, and liver. J Chromatogr A 2006;1104(1-2):222-229
74. Katajamaa M, Oresic M. Data processing for mass spectrometry-based metabolomics. J Chromatogr A 2007;1158(1-2):318-328
75. Smith CA, Want EJ, O'Maille G, et al. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem 2006;78(3):779-787
76. Baran R, Kochi H, Saito N, et al. MathDAMP: a package for differential analysis of metabolite profiles. BMC Bioinformatics 2006;7:530-538
77. Neuweger H, Albaum SP, Dondrup M, et al. MeltDB: a software platform for the analysis and integration of metabolomics experiment data. Bioinformatics 2008;24(23):2726-2732
78. Xia J, Psychogios N, Young N, Wishart DS. MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Res 2009;37(Web Server):W652-60
79. Mendes P. Emerging bioinformatics for the metabolome. Brief Bioinform 2002;3(2):134-145
80. Sumner Lloyd W, Mendes P, Dixon Richard A. Plant metabolomics: large-scale phytochemistry in the functional genomics era. Phytochemistry 2003;62(6):817-836
81. Alter O, Brown PO, Botstein D. Singular value decomposition for genome-wide expression data processing and modeling. Proc Natl Acad Sci USA 2000;97(18):10101-10106
82. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998;95(25):14863- 14868
83. Churchill GA. Using ANOVA to analyze microarray data. BioTechniques 2004;37(2):173-5, 7
84. Musumarra G, Barresi V, Condorelli DF, Scire S. A bioinformatic approach to the identification of candidate genes for the development of new cancer diagnostics. Biol Chem 2003;384(2):321-327
85. Faber NM, Rajko R. How to avoid over-fitting in multivariate calibration- The conventional validation approach and an alternative. Anal Chim Acta 2007;595(1-2):98-106
86. Kind T, Fiehn O. Metabolomic database annotations via query of elemental compositions: mass accuracy is insufficient even at less than 1 ppm. BMC Bioinformatics 2006;7:234-244
87. Kanehisa M, Goto S, Kawashima S, Nakaya A. The KEGG databases at GenomeNet. Nucleic Acids Res 2002;30(1):42-46
88. Okuda S, Yamada T, Hamajima M, et al. KEGG Atlas mapping for global analysis of metabolic pathways. Nucleic Acids Res 2008; 36(Web Server):W423-6
89. Wishart David S. Applications of metabolomics in drug discovery and development. Drugs R D 2008;9(5):307-322
90. Robertson DG. Metabonomics in toxicology: a review. Toxicol Sci 2005;85(2):809-822
91. Griffin JL, Nicholls AW. Metabolomics as a functional genomic tool for understanding lipid dysfunction in diabetes, obesity and related disorders. Pharmacogenomics 2006;7(7):1095-1107
92. Zivkovic Angela M, German JB. Metabolomics for assessment of nutritional status. Curr Opin Clin Nutr Metab Care 2009;12(5):501-507
93. Serkova Natalie J, Glunde K. Metabolomics of cancer. Methods Mol Biol 2009;520:273-295
94. Barba I, Fernandez-Montesinos R, Garcia-Dorado D, Pozo D. Alzheimer's disease beyond the genomic era: nuclear magnetic resonance (NMR) spectroscopy-based metabolomics. J Cell Mol Med 2008;12(5A):1477-1485
95. Quinones MP, Kaddurah-Daouk R. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases. Neurobiol Dis 2009;35(2):165-176
96. Lewis Gregory D, Asnani A, Gerszten Robert E. Application of metabolomics to cardiovascular biomarker and pathway discovery. J Am Coll Cardiol 2008;52(2):117-123
97. Sreekumar A, Poisson Laila M, Rajendiran Thekkelnaycke M, et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 2009;457(7231):910-914
98. Investigational New Drug Application. 2009; Available from: http://www.fda.gov/ Drugs/DevelopmentApprovalProcess [cited]
99. Beloqui A, Guazzaroni M-E, Pazos F, et al. Reactome array: forging a link between metabolome and genome. Science 2009;326(5950):252-257